AABB Now Accepting ‘Ask the FDA and CMS/CLIA’ Questions

AABB encourages members to submit questions for the "Ask the FDA and CMS/CLIA" session at the 2025 AABB Annual Meeting. This popular session provides an opportunity for members to submit questions to FDA and CMS/CLIA representatives regarding the agencies’ current thinking on policies, regulations, guidance documents and inspection programs relevant to the oversight of blood and biotherapies.

When submitting questions, individuals should identify the regulation or recommendation of interest, the specific issue or concern, and any background information, as well as suggestions or proposed solutions to best illustrate their perspective. Only questions submitted in advance will be considered. Please submit questions by Aug 8.